Filter by
Filter by
Prostate Cancer
Jason Efstathiou gives an overview of protons for prostate cancer. He covers the clinical potential, the available and comparative data, and the future...
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
This study compared the bowel function (BF), urinary irritative/obstructive symptoms (UO), and urinary incontinence (UI) domains of EPIC-26 collected in 262...
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
Published in the Green Journal, this systematic review analyzed 160 studies of hypofractionated PT (n=11) or XRT (n=148) or PT+XRT (n=1) for localized prostate...
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
This study from Japan reported 45 cases of localized prostate cancer treated with real-time image-gated spot-scanning proton therapy (RGPT) where 3 to 4 pure...
A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity-Modulated Radiation Therapy in Early Stage Prostate Cancer Patients.
This multi-institutional study compared late toxicity profiles of a total of 1850 patients, including 1282 IMRT and 568 PBT. Overall toxicity rates were low...
Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial.
Based on the PCG registry data, this is the largest study evaluating outcomes of 605 patients with localized high-risk prostate cancer (HRPC) treated with...